Ziogas J, Story D F
Department of Pharmacology, University of Melbourne, Victoria, Australia.
J Hypertens Suppl. 1987 Jul;5(2):S47-52. doi: 10.1097/00004872-198707002-00009.
The effects of angiotensin II and its precursors angiotensin I and tetradecapeptide renin substrate were investigated in isolated segments of the rat caudal artery. Each peptide constricted the rat caudal artery and also enhanced vasoconstrictor responses to sympathetic nerve stimulation (0.5 Hz, 10 s). The threshold concentrations for each peptide in enhancing sympathetic vasoconstrictor responses were lower than those required to produce vasoconstriction. Tetradecapeptide renin substrate was the least potent of the three peptides and had the slowest onset of action. Angiotensin II and angiotensin I each enhanced noradrenergic transmission to the same degree, whether perfused through the lumen or added to the adventitial surface of the artery. In contrast, tetradecapeptide renin substrate was more potent when applied to the adventitial surface. The effects of angiotensin I were blocked by the converting enzyme inhibitor enalaprilat, whereas the effects of tetradecapeptide renin substrate were unaltered by enalaprilat, or by the renin inhibitors pepstatin or a decapeptide renin inhibitor. These findings suggest that tetradecapeptide renin substrate and angiotensin I may be converted to angiotensin II within the rat caudal artery, with subsequent enhancement of noradrenergic neuroeffector function. However, the enzyme responsible for the conversion of tetradecapeptide renin substrate cannot be determined from the present findings.
在大鼠尾动脉离体节段中研究了血管紧张素II及其前体血管紧张素I和十四肽肾素底物的作用。每种肽均使大鼠尾动脉收缩,并增强了对交感神经刺激(0.5 Hz,10秒)的血管收缩反应。每种肽增强交感神经血管收缩反应的阈值浓度低于产生血管收缩所需的浓度。十四肽肾素底物是这三种肽中作用最弱的,且起效最慢。血管紧张素II和血管紧张素I无论是通过管腔灌注还是添加到动脉外膜表面,均以相同程度增强去甲肾上腺素能传递。相反,十四肽肾素底物应用于外膜表面时作用更强。血管紧张素I的作用可被转化酶抑制剂依那普利拉阻断,而十四肽肾素底物的作用不受依那普利拉、胃蛋白酶抑制剂或十肽肾素抑制剂的影响。这些发现提示,十四肽肾素底物和血管紧张素I可能在大鼠尾动脉内转化为血管紧张素II,随后增强去甲肾上腺素能神经效应功能。然而,根据目前的发现无法确定负责十四肽肾素底物转化的酶。